Australia markets closed

Genmab A/S (GNMSF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
289.74+13.27 (+4.80%)
At close: 03:40PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts881313
Avg. Estimate3.133.2611.4514.75
Low estimate2.452.710.411.74
High estimate4.023.7513.1217.52
Year ago EPS2.924.79.4911.45
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts661514
Avg. Estimate713.42M745.27M2.82B3.33B
Low estimate691.8M720.04M2.73B3.13B
High estimate758.43M763.42M2.88B3.53B
Year ago sales594.55M690.25M2.37B2.82B
Sales growth (year/est)20.00%8.00%19.30%18.10%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS2.713.013.311.76
Actual EPS2.924.71.392.9
Difference0.211.69-1.921.14
Surprise %7.70%56.10%-58.00%64.80%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate3.133.2611.4514.75
7 days ago3.123.2511.4614.96
30 days ago3.033.1911.1815.02
60 days ago33.1811.5615.51
90 days ago3.073.412.2416.01
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1122
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A23
Growth estimatesGNMSFIndustrySector(s)S&P 500
Current qtr.7.20%N/AN/AN/A
Next qtr.-30.60%N/AN/AN/A
Current year20.70%N/AN/AN/A
Next year28.80%N/AN/AN/A
Next 5 years (per annum)2.76%N/AN/AN/A
Past 5 years (per annum)30.11%N/AN/AN/A